Vistagen Therapeutics (VTGN) News Today → Musk’s new company could top a trillion? (From Paradigm Press) (Ad) Free VTGN Stock Alerts $3.68 -0.11 (-2.90%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 9 at 1:18 AM | americanbankingnews.comVistagen Therapeutics (VTGN) Scheduled to Post Earnings on TuesdayJune 7, 2024 | businesswire.comVistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024June 6, 2024 | marketbeat.comArmistice Capital LLC Takes $2.46 Million Position in Vistagen Therapeutics, Inc. (NASDAQ:VTGN)Armistice Capital LLC bought a new stake in Vistagen Therapeutics, Inc. (NASDAQ:VTGN - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 478,000 shares of the company's stMay 29, 2024 | businesswire.comVistagen to Present at the Jefferies Global Healthcare ConferenceMay 23, 2024 | businesswire.comVistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) ConferenceMay 14, 2024 | investorplace.com3 Must-Have Penny Stocks to Boost Your 2024 PortfolioMay 13, 2024 | investorplace.comMeme Stock Rebound: 3 Reddit Favorites Primed for a ResurgenceMay 8, 2024 | marketbeat.comVistagen Therapeutics (NASDAQ:VTGN) Share Price Crosses Below 50-Day Moving Average of $4.69Vistagen Therapeutics (NASDAQ:VTGN) Share Price Passes Below 50 Day Moving Average of $4.69May 7, 2024 | businesswire.comVistagen to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceApril 27, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: VistaGen Therapeutics (VTGN) and Acrivon Therapeutics, Inc. (ACRV)April 26, 2024 | msn.comVistagen reports positive results for mental fatigue treatmentApril 25, 2024 | businesswire.comVistagen Announces Positive Results from Phase 2A Pilot Study of PH15 for Improvement of Psychomotor Impairment Caused by Mental FatigueApril 24, 2024 | seekingalpha.comVistagen Therapeutics: A Pipeline With Potential In Anxiety And DepressionApril 19, 2024 | investorplace.com7 Stocks Under $15 Predicted to Boom in the Next 2 YearsApril 9, 2024 | investorplace.comMillionaire Makers: 3 Stocks Under $10 Set to Skyrocket by 2027April 9, 2024 | businesswire.comVistagen to Present at the 2024 Anxiety and Depression Association (ADAA) ConferenceApril 1, 2024 | finance.yahoo.comVistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2March 31, 2024 | investorplace.comSecret Superstars: 3 Unknown Stocks to Turn $5K into $100K by 2027March 28, 2024 | msn.comPDS Biotechnology GAAP EPS of -$1.39 beats by $0.06March 26, 2024 | finance.yahoo.com30 Countries with the Lowest Depression RatesMarch 20, 2024 | marketbeat.comVistagen Therapeutics (NASDAQ:VTGN) Share Price Crosses Below 50-Day Moving Average of $4.83Vistagen Therapeutics (NASDAQ:VTGN) Stock Passes Below Fifty Day Moving Average of $4.83March 17, 2024 | seekingalpha.comWhy VistaGen Therapeutics Is A Buy: Fasedienol Potential For Anxiety TreatmentsMarch 16, 2024 | finance.yahoo.comVTGN Apr 2024 10.000 callMarch 15, 2024 | cnbc.comThis overlooked corner of women's health could be a $350 billion market opportunityMarch 11, 2024 | businesswire.comVistagen to Present at Stifel 2024 Virtual CNS DaysFebruary 28, 2024 | finance.yahoo.comVistagen to Present at TD Cowen 44th Annual Health Care ConferenceFebruary 28, 2024 | businesswire.comVistagen to Present at TD Cowen 44th Annual Health Care ConferenceFebruary 22, 2024 | benzinga.comVistagen Therapeutics Stock (NASDAQ:VTGN), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comDoes VistaGen Therapeutics, Inc. (VTGN) Have the Potential to Rally 160% as Wall Street Analysts Expect?February 19, 2024 | investorplace.com3 Revolutionary Biotech Stocks Poised for 10X SurgeFebruary 16, 2024 | marketbeat.comFY2024 EPS Estimates for Vistagen Therapeutics, Inc. Boosted by Analyst (NASDAQ:VTGN)Vistagen Therapeutics, Inc. (NASDAQ:VTGN - Free Report) - Stock analysts at William Blair lifted their FY2024 earnings per share estimates for shares of Vistagen Therapeutics in a research report issued to clients and investors on Tuesday, February 13th. William Blair analyst T. Lugo now expectsFebruary 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for VistaGen: Promising Clinical Results and Strong Financial OutlookFebruary 15, 2024 | finance.yahoo.comVistagen Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 15, 2024 | finance.yahoo.comVistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2024 Earnings Call TranscriptFebruary 14, 2024 | investorplace.com3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market WaveFebruary 13, 2024 | morningstar.comVistagen Therapeutics Inc VTGNFebruary 13, 2024 | benzinga.comRecap: Vistagen Therapeutics Q3 EarningsFebruary 13, 2024 | msn.comVistagen Therapeutics files for $350M mixed shelfFebruary 13, 2024 | finance.yahoo.comVistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate UpdateFebruary 13, 2024 | finance.yahoo.comVistagen Therapeutics Inc (VTGN) Reports Fiscal 2024 Q3 Results: A Closer Look at Financials ...February 13, 2024 | businesswire.comVistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate UpdateFebruary 12, 2024 | msn.comVistaGen Therapeutics Q3 2024 Earnings PreviewFebruary 12, 2024 | benzinga.comVistaGen Therapeutics's Earnings: A PreviewFebruary 7, 2024 | finance.yahoo.comVistagen to Report Fiscal Year 2024 Third Quarter Financial Results and Host Corporate Update Conference Call on February 13, 2024February 7, 2024 | marketbeat.comVistagen Therapeutics (VTGN) Set to Announce Quarterly Earnings on TuesdayVistagen Therapeutics (NASDAQ:VTGN) will be releasing earnings after the market closes on Tuesday, February 13, Zacks reports.February 3, 2024 | marketbeat.comVistagen Therapeutics (NASDAQ:VTGN) Share Price Crosses Above Fifty Day Moving Average of $4.86Vistagen Therapeutics (NASDAQ:VTGN) Shares Cross Above Fifty Day Moving Average of $4.86January 30, 2024 | investing.comVistaGen Therapeutics Inc (VTGN)January 26, 2024 | marketbeat.comVistagen Therapeutics, Inc. (NASDAQ:VTGN) Sees Large Drop in Short InterestVistagen Therapeutics, Inc. (NASDAQ:VTGN - Get Free Report) was the recipient of a large decrease in short interest in the month of January. As of January 15th, there was short interest totalling 1,160,000 shares, a decrease of 28.8% from the December 31st total of 1,630,000 shares. Based on an average trading volume of 544,700 shares, the days-to-cover ratio is presently 2.1 days. Approximately 4.8% of the shares of the stock are sold short.January 23, 2024 | thestreet.comVistagen Therapeutics Inc.December 29, 2023 | finance.yahoo.comHow Vistagen (VTGN) Stock Stands Out in a Strong Industry Get Vistagen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Bill Clinton Backing Biden Replacement??? (Ad)Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be Trump. Click here to see why it will be ______ _________. VTGN Media Mentions By Week VTGN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VTGN News Sentiment▼0.510.75▲Average Medical News Sentiment VTGN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VTGN Articles This Week▼31▲VTGN Articles Average Week Get Vistagen Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MACK News SLRN News TBPH News PGEN News BMEA News TERN News VRCA News AMRN News NLTX News VTYX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VTGN) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | Sponsored